Cost Savings of Clarithomycin Compared With Erythromycin or Cefaclor in the Treatment of Lower Respiratory Tract Infection:  Results of a Randomized, Multicenter Study

Eugene M. Spiritus, MD;R Joanne Chang, MD, PhD;Jie X. Zhang, PhD;Richard C. Hom, MD, PhD;Gerard F. Notario, MD;Donald P. Conway, MD, MBA;

Publication

Article

October 1, 1998

Supplements and Featured Publications

Clinical and Economic Considerations of Antimicrobial Use

Volume4

Issue 11 Suppl

Cost Savings of Clarithomycin Compared With Erythromycin or Cefaclor in the Treatment of Lower Respiratory Tract Infection: Results of a Randomized, Multicenter Study

Author(s):

Eugene M. Spiritus, MD,R Joanne Chang, MD, PhD

Download PDF: Cost Savings of Clarithomycin Compared With Erythromycin or Cefaclor in the Treatment of Lower Respiratory Tract Infection: Results of a Randomized, Multicenter Study

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions

Cost Savings of Clarithomycin Compared With Erythromycin or Cefaclor in the Treatment of Lower Respiratory Tract Infection: Results of a Randomized, Multicenter Study

Newsletter